DK0750509T4 - Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme - Google Patents
Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdommeInfo
- Publication number
- DK0750509T4 DK0750509T4 DK95912666T DK95912666T DK0750509T4 DK 0750509 T4 DK0750509 T4 DK 0750509T4 DK 95912666 T DK95912666 T DK 95912666T DK 95912666 T DK95912666 T DK 95912666T DK 0750509 T4 DK0750509 T4 DK 0750509T4
- Authority
- DK
- Denmark
- Prior art keywords
- autoimmune
- preparation
- treatment
- antagonists
- autoimmune diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21262994A | 1994-03-14 | 1994-03-14 | |
PCT/US1995/002550 WO1995024918A1 (en) | 1994-03-14 | 1995-03-07 | Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0750509T3 DK0750509T3 (da) | 2002-07-08 |
DK0750509T4 true DK0750509T4 (da) | 2006-10-16 |
Family
ID=22791827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95912666T DK0750509T4 (da) | 1994-03-14 | 1995-03-07 | Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme |
Country Status (14)
Country | Link |
---|---|
US (1) | US6338848B1 (ja) |
EP (4) | EP2311484A1 (ja) |
JP (1) | JP3798426B2 (ja) |
AT (1) | ATE217533T1 (ja) |
AU (1) | AU689236B2 (ja) |
CA (1) | CA2185565C (ja) |
DE (1) | DE69526728T3 (ja) |
DK (1) | DK0750509T4 (ja) |
ES (1) | ES2173953T5 (ja) |
IL (1) | IL112677A (ja) |
PT (1) | PT750509E (ja) |
TW (1) | TW400233B (ja) |
WO (1) | WO1995024918A1 (ja) |
ZA (1) | ZA95960B (ja) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6683046B1 (en) | 1989-12-22 | 2004-01-27 | Hoffmann-La Roche Inc. | Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
US6706264B1 (en) * | 1994-03-14 | 2004-03-16 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
US5853697A (en) * | 1995-10-25 | 1998-12-29 | The United States Of America, As Represented By The Department Of Health & Human Services | Methods of treating established colitis using antibodies against IL-12 |
AU4959997A (en) * | 1996-11-15 | 1998-06-10 | Kennedy Institute Of Rheumatology, The | Suppression of tnf alpha and il-12 in therapy |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
CA2318052C (en) * | 1998-01-23 | 2012-07-03 | F. Hoffmann-La Roche Ag | Antibodies against human il-12 |
US7026456B1 (en) | 1998-01-23 | 2006-04-11 | Hoffman-La Roche, Inc. | Antibodies against human IL-12 |
CA2353520C (en) * | 1998-12-09 | 2006-04-25 | Protein Design Labs, Inc. | Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
KR100659007B1 (ko) | 1999-02-10 | 2007-02-28 | 미츠비시 웰파마 가부시키가이샤 | 아미드 화합물 및 그 의약으로서의 용도 |
US6914128B1 (en) | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
NZ592550A (en) * | 1999-03-25 | 2012-12-21 | Abbott Gmbh & Co Kg | Compostion comprising antibody capable of binding to p40 subunit of IL-12 |
US7883704B2 (en) | 1999-03-25 | 2011-02-08 | Abbott Gmbh & Co. Kg | Methods for inhibiting the activity of the P40 subunit of human IL-12 |
AU2005200515B2 (en) * | 1999-03-25 | 2006-07-13 | AbbVie Deutschland GmbH & Co. KG | Human antibodies that bind human IL-12 and methods for producing |
JP4676049B2 (ja) * | 1999-07-21 | 2011-04-27 | 生化学工業株式会社 | Il−12産生抑制剤 |
US6346247B1 (en) * | 1999-10-28 | 2002-02-12 | Promega Corporation | Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
US7115712B1 (en) | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
US6902734B2 (en) | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
AU2003218432A1 (en) * | 2002-03-26 | 2003-10-13 | Centocor, Inc. | Diabetes-related immunoglobulin derived proteins, compositions, methods and uses |
CA2548179A1 (en) | 2003-12-02 | 2005-07-21 | Cytimmune Sciences, Inc. | Methods and compositions for the production of monoclonal antibodies |
GB0329146D0 (en) * | 2003-12-16 | 2004-01-21 | Glaxosmithkline Biolog Sa | Vaccine |
WO2005085866A1 (en) * | 2004-02-27 | 2005-09-15 | Novartis Ag | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
US7943294B2 (en) * | 2004-07-30 | 2011-05-17 | Hologic, Inc. | Methods for detecting oncofetal fibronectin |
CN101120087A (zh) | 2004-12-21 | 2008-02-06 | 森托科尔公司 | 抗-il-12抗体、表位、组合物、方法和用途 |
US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
EP2500352A1 (en) | 2005-08-19 | 2012-09-19 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
EP2500359A3 (en) | 2005-08-19 | 2012-10-17 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
AU2008205512B2 (en) | 2007-01-16 | 2014-06-12 | Abbvie Inc. | Methods for treating psoriasis |
CN101679507A (zh) | 2007-03-29 | 2010-03-24 | 艾博特公司 | 结晶抗人类il-12抗体 |
WO2009117289A2 (en) | 2008-03-18 | 2009-09-24 | Abbott Laboratories | Methods for treating psoriasis |
US9029508B2 (en) | 2008-04-29 | 2015-05-12 | Abbvie Inc. | Dual variable domain immunoglobulins and uses thereof |
EP3002299A1 (en) | 2008-06-03 | 2016-04-06 | AbbVie Inc. | Dual variable domain immunoglobulins and uses thereof |
CN102112494A (zh) | 2008-06-03 | 2011-06-29 | 雅培制药有限公司 | 双重可变结构域免疫球蛋白及其用途 |
JP5674654B2 (ja) | 2008-07-08 | 2015-02-25 | アッヴィ・インコーポレイテッド | プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用 |
MX2011003347A (es) * | 2008-09-30 | 2011-05-25 | Baylor Res Inst | Metodos para reducir celulas t, b-auxiliares para tratar enfermedades autoinmunes. |
EP2350649A4 (en) * | 2008-11-28 | 2012-11-14 | Abbott Lab | STABLE ANTIBODY COMPOSITIONS AND METHODS FOR STABILIZING THE SAME |
EP2473524A4 (en) | 2009-09-01 | 2013-05-22 | Abbott Lab | IMMUNOGLOBULINE WITH DOUBLE VARIABLE DOMAIN AND ITS USE |
RU2012114854A (ru) | 2009-09-14 | 2013-10-27 | Эбботт Лэборетриз | Способы лечения псориаза |
KR20140015139A (ko) | 2009-10-15 | 2014-02-06 | 애브비 인코포레이티드 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
WO2011051466A1 (en) | 2009-11-02 | 2011-05-05 | Novartis Ag | Anti-idiotypic fibronectin-based binding molecules and uses thereof |
WO2012006500A2 (en) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
CN103298834A (zh) | 2010-08-03 | 2013-09-11 | Abbvie公司 | 双重可变结构域免疫球蛋白及其用途 |
BR112013004581A2 (pt) | 2010-08-26 | 2017-06-27 | Abbvie Inc | imunoglobulinas de domínio variável dual e seus usos |
US8962317B2 (en) | 2010-09-28 | 2015-02-24 | Neumedicines, Inc. | Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration |
KR20130133247A (ko) | 2010-12-21 | 2013-12-06 | 애브비 인코포레이티드 | Il-1-알파 및 -베타 이특이적 이원 가변 도메인 면역글로불린 및 이의 용도 |
CA2836473C (en) * | 2011-05-19 | 2020-07-14 | Rush University Medical Center | Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment |
WO2013016634A1 (en) * | 2011-07-27 | 2013-01-31 | Neumedicines, Inc. | Use of il-12 to generate endogenous erythropoietin |
AR089529A1 (es) | 2011-12-30 | 2014-08-27 | Abbvie Inc | Proteinas de union especificas duales dirigidas contra il-13 y/o il-17 |
PE20151179A1 (es) | 2012-11-01 | 2015-09-12 | Abbvie Inc | Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas |
BR112015023797A2 (pt) | 2013-03-15 | 2017-10-24 | Abbvie Inc | proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17 |
WO2016094881A2 (en) | 2014-12-11 | 2016-06-16 | Abbvie Inc. | Lrp-8 binding proteins |
TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗vegf、pdgf及/或其受體之結合蛋白 |
EA201892190A1 (ru) | 2016-03-29 | 2019-04-30 | Янссен Байотек, Инк. | Лечение псориаза антителом к ил-12 и/или ил-23 с возрастанием интервала между введениями дозы |
TW201922780A (zh) * | 2017-09-25 | 2019-06-16 | 美商健生生物科技公司 | 以抗il12/il23抗體治療狼瘡之安全且有效之方法 |
JP7421500B2 (ja) | 2018-05-18 | 2024-01-24 | ヤンセン バイオテツク,インコーポレーテツド | 抗il12/il23抗体でループスを治療する安全かつ有効な方法 |
US10961307B2 (en) | 2018-09-24 | 2021-03-30 | Janssen Biotech, Inc. | Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody |
CN113874073A (zh) | 2019-05-23 | 2021-12-31 | 詹森生物科技公司 | 用针对IL-23和TNFα的抗体的联合疗法治疗炎性肠病的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
DE69034249T2 (de) | 1989-12-22 | 2008-05-29 | F. Hoffmann-La Roche Ag | Monoklonale Antikörper spezifisch für den zytotoxischen Lymphozyten-Reifefaktor |
GB9207732D0 (en) * | 1992-04-06 | 1992-05-27 | Isis Innovation | Wound repair |
DE4315127A1 (de) * | 1993-05-07 | 1994-11-10 | Behringwerke Ag | Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12 |
CA2125763C (en) † | 1993-07-02 | 2007-08-28 | Maurice Kent Gately | P40 homodimer of interleukin-12 |
EP0638644A1 (en) * | 1993-07-19 | 1995-02-15 | F. Hoffmann-La Roche Ag | Receptors of interleukin-12 and antibodies |
US5536657A (en) * | 1993-07-19 | 1996-07-16 | Hoffmann-La Roche Inc. | Recombinant DNA encoding human receptor for interleukin-12 |
US5853721A (en) * | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
CN1300173C (zh) * | 1996-02-09 | 2007-02-14 | 艾博特生物技术有限公司 | 结合人TNFα的人抗体 |
US5969102A (en) * | 1997-03-03 | 1999-10-19 | St. Jude Children's Research Hospital | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
TR199902615T2 (xx) * | 1997-03-18 | 2000-03-21 | Basf Aktiengesellschaft | Kortikosteroidlere verilen cevab�n mod�lasyonuna y�nelik metodlar ve kompozisyonlar. |
CA2318052C (en) * | 1998-01-23 | 2012-07-03 | F. Hoffmann-La Roche Ag | Antibodies against human il-12 |
US8700033B2 (en) | 2008-08-22 | 2014-04-15 | International Business Machines Corporation | Dynamic access to radio networks |
CN102377479B (zh) | 2010-08-11 | 2015-01-21 | 华为技术有限公司 | 数据同步方法及系统、光网络单元 |
-
1995
- 1995-02-07 ZA ZA95960A patent/ZA95960B/xx unknown
- 1995-02-14 TW TW084101380A patent/TW400233B/zh not_active IP Right Cessation
- 1995-02-16 IL IL11267795A patent/IL112677A/xx not_active IP Right Cessation
- 1995-03-07 DE DE69526728T patent/DE69526728T3/de not_active Expired - Lifetime
- 1995-03-07 EP EP10184543A patent/EP2311484A1/en not_active Withdrawn
- 1995-03-07 AU AU19749/95A patent/AU689236B2/en not_active Expired
- 1995-03-07 PT PT95912666T patent/PT750509E/pt unknown
- 1995-03-07 WO PCT/US1995/002550 patent/WO1995024918A1/en active IP Right Grant
- 1995-03-07 CA CA002185565A patent/CA2185565C/en not_active Expired - Lifetime
- 1995-03-07 JP JP52404495A patent/JP3798426B2/ja not_active Expired - Lifetime
- 1995-03-07 EP EP01117762A patent/EP1179348A3/en not_active Withdrawn
- 1995-03-07 EP EP10156687A patent/EP2201959A3/en not_active Withdrawn
- 1995-03-07 ES ES95912666T patent/ES2173953T5/es not_active Expired - Lifetime
- 1995-03-07 EP EP95912666A patent/EP0750509B2/en not_active Expired - Lifetime
- 1995-03-07 DK DK95912666T patent/DK0750509T4/da active
- 1995-03-07 AT AT95912666T patent/ATE217533T1/de active
-
2000
- 2000-02-25 US US09/513,380 patent/US6338848B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT750509E (pt) | 2002-08-30 |
DE69526728T2 (de) | 2002-11-21 |
EP2201959A2 (en) | 2010-06-30 |
ATE217533T1 (de) | 2002-06-15 |
CA2185565C (en) | 2009-02-03 |
IL112677A0 (en) | 1995-05-26 |
EP1179348A2 (en) | 2002-02-13 |
ES2173953T5 (es) | 2007-03-01 |
CA2185565A1 (en) | 1995-09-21 |
DE69526728D1 (de) | 2002-06-20 |
AU1974995A (en) | 1995-10-03 |
WO1995024918A1 (en) | 1995-09-21 |
EP1179348A3 (en) | 2003-12-03 |
AU689236B2 (en) | 1998-03-26 |
EP2201959A3 (en) | 2011-03-16 |
JPH09510444A (ja) | 1997-10-21 |
EP2311484A1 (en) | 2011-04-20 |
IL112677A (en) | 2000-01-31 |
DK0750509T3 (da) | 2002-07-08 |
EP0750509B2 (en) | 2006-06-14 |
ZA95960B (en) | 1995-10-10 |
ES2173953T3 (es) | 2002-11-01 |
EP0750509B1 (en) | 2002-05-15 |
DE69526728T3 (de) | 2007-01-04 |
US6338848B1 (en) | 2002-01-15 |
JP3798426B2 (ja) | 2006-07-19 |
TW400233B (en) | 2000-08-01 |
EP0750509A1 (en) | 1997-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0750509T4 (da) | Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme | |
ATE411029T1 (de) | Estrogene als antimitotika | |
IT1212892B (it) | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica | |
WO1994007535A3 (en) | Labelled interleukin-8 and medical uses thereof | |
DE69022501D1 (de) | Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten. | |
DK2795A (da) | Fremgangsmåde til fremstilling af 4-substituerede 3-(1'-hydroxyethyl)-azetidin-2-oner samt azetidin-2-on-derivat | |
IT1229506B (it) | Polimero dell'acido acrilico esente da solventi residui e procedimento per la sua preparazione. | |
IT1238825B (it) | Dispositivo per la correzione chirurgica dell'ametropia. | |
IL95412A0 (en) | Pharmaceutical compositions containing 5-methyl-isoxazole-4-carboxylic acid anilide derivatives and 2-hydroxy-ethylidene-cyano acetic acid anilide derivatives | |
NO177148C (no) | Fluorelastomerer basert på vinylidenfluorid, heksafluorpropen og tetrafluoretylen, samt anvendelse av slike | |
SE9402370D0 (sv) | Use of IGF-I | |
Schorlemmer et al. | Immunomodulatory activity of recombinant IL-1 receptor (IL-1-R) on models of experimental rheumatoid arthritis | |
Rosenbaum | Treating hair pulling in a 7-year-old male: Modified habit reversal for use in pediatric settings | |
Neistadt et al. | A program for sex counseling the physically disabled. | |
KR910009255A (ko) | 과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체 | |
IT7950444A0 (it) | N-(1-metil 2-pirrolidinilmetil) 2,3dimetossi-5-metilsolfamoil benzammide e suoi derivati utili per il trattamento dei disturbi dell'appa rato urinario e procedimento di preparazione | |
Finnerty-Fried | Adapting rehabilitation counseling for older persons. | |
Sakamoto et al. | A Case Report of Multiple Tendon Xanthomas | |
Zuk | Methodology for evaluating the aesthetic appeal of bridge designs | |
Heye et al. | Investigation of use of alternative treatment methods by patients with rheumatoid arthritis | |
Hawkins | I recently saw a patient with a most unusual inflammatory arthritis of the knee. Deliberate self-harm was suggested by the general practitioner. How should I evaluate this possibility, and if necessary treat the problem? | |
Bonnie Rogers | National Center for Nursing Research | |
Tohyama et al. | Long-Term Functional Prognosis and CT Findings of Patients with Crush Syndrome from the Hanshin-Awaji Earthquake | |
IT1122095B (it) | Metodo per la terapia dell'artrite reumatoide e formulazioni farmaceutiche idonee allo scopo | |
IT7886233A0 (it) | Stampelle ginniche con sottoascella ri molleggiati,atte alla cura di disturbi miostonici ed artrosici |